Camber launches generic Noxafi
PISCATAWAY, N.J.– Camber Pharmaceuticals is pleased to announce the addition of posaconazole delayed-release tablets to its current portfolio.
Supplier News
Bill introduced to include dietary supplements in FSA/HSA accounts
organizations representing dietary supplement manufacturers, marketers, and ingredient suppliers—applaud the introduction of the Dietary Supplements Access Act. This bipartisan legislation, introduced today by U.S.
Retailers uncork big sales with private label wine
Raise a glass to private label wine: dollar sales in all U.S. outlets jumped 9.1% to $52.2 million for the 52 weeks ending June 18, 2023, versus the same period the prior year, according to data from Circana. What’s more, unit sales grew 8% for the same period. Store brand spirits are
Chewsy launches vitamin lines in CVS Pharmacy
Chewsy, a leading provider of candy style vitamin chews, has announced the launch of Beautiful Hair, So Long Stress, and Women’s Multi chews to CVS Pharmacy customers nationwide.
Integra brand to transition into RedSail Technologies
SPARTANBURG, S.C. – RedSail Technologies, parent company of leading long-term care pharmacy innovator, Integra, announced the convergence of these brands into one – RedSail Technologies.
Aurobindo gets FDA approval for apremilast tablets
EAST WINDSOR, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application apremilast tablets, 10mg, 20mg, and 30mg.
Aurobindo receives FDA approval for hydrocortisone tablets
EAST WINDSOR, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Hydrocortisone Tablets USP, 5 mg, 10mg, and 20mg.
PanOxy announces the return of its 10% Benzoyl Peroxide Acne Treatment Bar
Crown Therapeutics, a division of Crown Laboratories, Inc., announces the launch of its PanOxyl 10% Benzoyl Peroxide Acne Treatment Bar. Due to consumer demand, PanOxyl has brought back this beloved product, delivering a powerful solution to those battling acne and promoting clearer, healthier skin.
LexisNexis Reed Tech expands portfolio
LexisNexis Reed Tech, a leading provider of regulatory submissions, data management and analytics solutions for the life sciences industry, is expanding its services portfolio to offer end-to-end eCTD solutions and services to support manufacturers, distributors and related operations.
Aurobindo receives FDA approval for ertugliflozin tablets
EAST WINDSOR, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application ertugliflozin tablets, 5mg and 15mg.
Special Report: Panelists delve into Walgreens’ retail media network
In December 2020, Walgreens made its debut in the fast-growing retail advertising field with the launch of Walgreens Advertising Group (wag).
Eli Lilly’s experimental Alzheimer’s drug slows progression of the disease
Eli Lilly and Co. presented full results from the Phase 3 TRAILBLAZER-ALZ 2 study showing that donanemab significantly slowed cognitive and functional decline in people with early symptomatic Alzheimer’s disease (AD).
RedSail Technologies announces integration between Axys and Etactics
RedSail Technologies, developer of Axys, is proud to announce the launch of its integration with Etactics, a premier revenue cycle management platform.
Making the most of the 2023 Total Store Expo
The NACDS Total Store Expo is deservedly one of the most highly anticipated events on the retail industry’s calendar. Whether you’re a retailer, supplier or industry enthusiast, attending TSE offers valuable opportunities to connect, learn and grow. It is a big event, with a lot going on.
Aurobindo receives FDA approval for sevelamer hydrochloride tablets
Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application sevelamer hydrochloride tablets 400mg and 800mg.
Aurobindo receives FDA approval for ramelteon tablets
EAST WINDSOR, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application ramelteon tablets, 8mg.